“…The pharmaceutical manufacture of a drug substance and subsequent development of a drug product will generally, at some stage in the program, involve interactions between a solvent and the active pharmaceutical ingredients or excipients. This may, for example, include recrystallisation1 and drying of the drug substance, wet granulation with excipients in the presence of an appropriate solvent,2 lyophilisation, or spray drying. Solvent interactions can be critical to the quality and performance of the final product,2,3,4 whether it be through controlling the polymorphic form, formation of solvates, or desolvation.…”